Molecular Epidemiology of CTX-M-Producing Escherichia coli Isolates at a Tertiary Medical Center in Western Pennsylvania

ABSTRACT A combination of phenotypic and genotypic methods was used to investigate 70 unique Escherichia coli clinical isolates identified as producing extended-spectrum β-lactamases (ESBLs) at a medical center in Pittsburgh, PA, between 2007 and 2008. Fifty-seven isolates (81%) produced CTX-M-type ESBLs, among which CTX-M-15 was predominant (n = 46). Isolates producing CTX-M-2, -9, -14, and -65 were also identified. One CTX-M-producing isolate coproduced CMY-2 cephalosporinase. Ten isolates (14%) produced SHV-type ESBLs, either SHV-5 or SHV-7. Two isolates produced only CMY-2 or -32. Pulsed-field gel electrophoresis revealed the presence of two major clusters of CTX-M-15-producing E. coli isolates, one in phylotype B2 (n = 15) and the other in phylotype A (n = 19). Of four phylotype B2 isolates that were able to transfer the blaCTX-M-15-carrying plasmids, three showed fingerprints related (>60%) to those of plasmids from phylotype A isolates. In phylotype B2, all CTX-M-15-producing isolates, as well as three isolates producing CTX-M-14, two producing SHV-5, and one producing SHV-7, belonged to the international epidemic clone defined by serotype O25:H4 and sequence type 131. The plasmids from eight of nine CTX-M-15-producing E. coli isolates of phylotype A that were examined were highly related to each other and were also found in two isolates belonging to phylotype D, suggesting horizontal transfer of this blaCTX-M-15-carrying plasmid between phylotypes. Our findings underscore the need to further investigate the epidemiology and virulence of CTX-M-producing E. coli in the United States.

[1]  I. Nachamkin,et al.  Prevalence of CTX-M β-Lactamases in Philadelphia, Pennsylvania , 2009, Journal of Clinical Microbiology.

[2]  D. Paterson,et al.  Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Y. Arakawa,et al.  Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread. , 2008, The Journal of antimicrobial chemotherapy.

[4]  F. J. L. Robberts,et al.  Unreliable Extended-Spectrum β-Lactamase Detection in the Presence of Plasmid-Mediated AmpC in Escherichia coli Clinical Isolates , 2008, Journal of Clinical Microbiology.

[5]  M. Kaufmann,et al.  UK epidemic Escherichia coli strains A-E, with CTX-M-15 beta-lactamase, all belong to the international O25:H4-ST131 clone. , 2008, The Journal of antimicrobial chemotherapy.

[6]  P. Edelstein.  Prevalence of CTX-M β-lactamases in Philadelphia , 2008 .

[7]  L. Guize,et al.  Absence of CTX-M Enzymes but High Prevalence of Clones, Including Clone ST131, among Fecal Escherichia coli Isolates from Healthy Subjects Living in the Area of Paris, France , 2008, Journal of Clinical Microbiology.

[8]  Ronald N. Jones,et al.  Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. Medical Centers: molecular evaluation from the MYSTIC Program (2007). , 2008, Microbial drug resistance.

[9]  J. Lavigne,et al.  Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. , 2008, The Journal of antimicrobial chemotherapy.

[10]  D. Paterson,et al.  High prevalence of CTX-M-15-producing Klebsiella pneumoniae among inpatients and outpatients with urinary tract infection in Southern India. , 2008, The Journal of antimicrobial chemotherapy.

[11]  E. Denamur,et al.  The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. , 2008, The Journal of antimicrobial chemotherapy.

[12]  D. Paterson,et al.  Multiclonal Outbreak of Klebsiella pneumoniae Producing Extended-Spectrum β-Lactamase CTX-M-2 and Novel Variant CTX-M-59 in a Neonatal Intensive Care Unit in Brazil , 2008, Antimicrobial Agents and Chemotherapy.

[13]  B. Wickes,et al.  First Report of the Emergence of CTX-M-Type Extended-Spectrum β-Lactamases (ESBLs) as the Predominant ESBL Isolated in a U.S. Health Care System , 2008, Antimicrobial Agents and Chemotherapy.

[14]  F. Baquero,et al.  Dissemination of Clonally Related Escherichia coli Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15 , 2008, Emerging infectious diseases.

[15]  J. Blanco,et al.  Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. , 2007, The Journal of antimicrobial chemotherapy.

[16]  A. Apisarnthanarak,et al.  Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study. , 2007, American journal of infection control.

[17]  A. Carattoli,et al.  Molecular Epidemiology of Escherichia coli Producing Extended-Spectrum β-Lactamases Isolated in Rome, Italy , 2007, Journal of Clinical Microbiology.

[18]  D. Paterson,et al.  Community-acquired extended-spectrum beta-lactamase producers, United States. , 2007, Emerging infectious diseases.

[19]  M. Souli,et al.  Detection of CTX-M-15 and CTX-M-33, a novel variant of CTX-M-15, in clinical Escherichia coli isolates in Greece. , 2007, International journal of antimicrobial agents.

[20]  N. Woodford,et al.  CTX-M: changing the face of ESBLs in Europe. , 2006, The Journal of antimicrobial chemotherapy.

[21]  R. Cantón,et al.  The CTX-M β-lactamase pandemic , 2006 .

[22]  A. Robicsek,et al.  Prevalence in the United States of aac(6′)-Ib-cr Encoding a Ciprofloxacin-Modifying Enzyme , 2006, Antimicrobial Agents and Chemotherapy.

[23]  N. Woodford,et al.  Molecular characterization of plasmids encoding CTX-M-15 beta-lactamases from Escherichia coli strains in the United Kingdom. , 2006, The Journal of antimicrobial chemotherapy.

[24]  David L Paterson.  Resistance in gram-negative bacteria: enterobacteriaceae. , 2006, The American journal of medicine.

[25]  B. Swaminathan,et al.  Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. , 2006, Foodborne pathogens and disease.

[26]  R. Cantón,et al.  The CTX-M beta-lactamase pandemic. , 2006, Current opinion in microbiology.

[27]  A. Manges,et al.  Analysis of a Uropathogenic Escherichia coli Clonal Group by Multilocus Sequence Typing , 2005, Journal of Clinical Microbiology.

[28]  S. Campoy,et al.  Characterization of the highly variable region surrounding the bla(CTX-M-9) gene in non-related Escherichia coli from Barcelona. , 2005, The Journal of antimicrobial chemotherapy.

[29]  D. Livermore,et al.  CTX-M: changing the face of ESBLs in the UK. , 2005, The Journal of antimicrobial chemotherapy.

[30]  D. Church,et al.  Community-Wide Outbreaks of Clonally Related CTX-M-14 β-Lactamase-Producing Escherichia coli Strains in the Calgary Health Region , 2005, Journal of Clinical Microbiology.

[31]  M. Gardam,et al.  Complete Nucleotide Sequence of a 92-Kilobase Plasmid Harboring the CTX-M-15 Extended-Spectrum Beta-Lactamase Involved in an Outbreak in Long-Term-Care Facilities in Toronto, Canada , 2004, Antimicrobial Agents and Chemotherapy.

[32]  R. Bonnet.  Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes , 2004, Antimicrobial Agents and Chemotherapy.

[33]  M. Pimkin,et al.  Prevalence and Molecular Epidemiology of CTX-M Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Russian Hospitals , 2003, Antimicrobial Agents and Chemotherapy.

[34]  A. Hossain,et al.  Discovery of CTX-M-Like Extended-Spectrum β-Lactamases in Escherichia coli Isolates from Five U.S. States , 2003, Antimicrobial Agents and Chemotherapy.

[35]  P. Nordmann,et al.  Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum β-lactamase CTX-M-15 and of its structurally related β-lactamase CTX-M-3 , 2002 .

[36]  C. Branger,et al.  Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. , 2002, The Journal of antimicrobial chemotherapy.

[37]  P. Nordmann,et al.  Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. , 2001, FEMS microbiology letters.

[38]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .

[39]  O. Clermont,et al.  Rapid and Simple Determination of theEscherichia coli Phylogenetic Group , 2000, Applied and Environmental Microbiology.

[40]  J. Barbé,et al.  Cloning and Sequence of the Gene Encoding a Novel Cefotaxime-Hydrolyzing β-Lactamase (CTX-M-9) fromEscherichia coli in Spain , 2000, Antimicrobial Agents and Chemotherapy.